Atlas Trials

Rapamycin for Prevention of Chronic Graft-Versus-Host Disease

Clinical trial NCT00623012 · TERMINATED

Trial details

NCT number
NCT00623012
Sponsor
Yale University
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Graft Versus Host Disease
Start date
2008-02-01
Primary completion
2013-08-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.